Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. (Q38540380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

Christele Desbois-Mouthon

18 February 2020

author

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hamza Chettouh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Marie Lequoy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Laetitia Fartoux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Corinne Vigouroux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

23 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

2203-2217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26123841%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of viral hepatitis and hepatocellular carcinoma

18 February 2020

cites work

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

NAFLD, NASH and liver cancer

21 January 2018

1 reference

Non-viral causes of hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

21 January 2018

1 reference

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.

21 January 2018

1 reference

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

21 January 2018

1 reference

Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.

21 January 2018

1 reference

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

21 January 2018

1 reference

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

21 January 2018

1 reference

Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study

21 January 2018

1 reference

Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study

21 January 2018

1 reference

Insulin action on the liver in vivo

21 January 2018

1 reference

Insulin induces swelling-dependent activation of the epidermal growth factor receptor in rat liver

21 January 2018

1 reference

Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesis

21 January 2018

1 reference

Insulin receptor signaling in normal and insulin-resistant states

21 January 2018

1 reference

Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1

21 January 2018

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management

21 January 2018

1 reference

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Molecular mechanisms of insulin resistance in chronic hepatitis C

21 January 2018

1 reference

Insulin resistance, steatosis and hepatitis C virus.

21 January 2018

1 reference

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

21 January 2018

1 reference

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein

21 January 2018

1 reference

Mechanisms for insulin resistance: common threads and missing links

21 January 2018

1 reference

Relationship of hepatitis C virus infection with diabetes in the U.S. population

21 January 2018

1 reference

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

21 January 2018

1 reference

Non-alcoholic steatohepatitis: a microbiota-driven disease.

21 January 2018

1 reference

Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease

21 January 2018

1 reference

Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance

21 January 2018

1 reference

Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity.

21 January 2018

1 reference

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

21 January 2018

1 reference

Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies

21 January 2018

1 reference

Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort

21 January 2018

1 reference

Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults

21 January 2018

1 reference

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

21 January 2018

1 reference

Risk of cancer in a large cohort of U.S. veterans with diabetes.

21 January 2018

1 reference

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

21 January 2018

1 reference

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

21 January 2018

1 reference

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

21 January 2018

1 reference

Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

Mechanisms of obesity-induced gastrointestinal neoplasia

21 January 2018

1 reference

21 January 2018

Obesity and liver cancer

1 reference

Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies

21 January 2018

1 reference

Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort

21 January 2018

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

Body-mass index and progression of hepatitis B: a population-based cohort study in men.

21 January 2018

1 reference

Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients

21 January 2018

1 reference

Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States

21 January 2018

1 reference

Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

Metabolic syndrome and risk of cancer: a systematic review and meta-analysis

21 January 2018

1 reference

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

21 January 2018

1 reference

Metabolic syndrome and hepatocellular carcinoma risk

21 January 2018

1 reference

Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective

21 January 2018

1 reference

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection

21 January 2018

1 reference

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort

21 January 2018

1 reference

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer

21 January 2018

1 reference

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.

21 January 2018

1 reference

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

21 January 2018

1 reference

Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma

21 January 2018

1 reference

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.

21 January 2018

1 reference

Antihyperglycaemic therapies and cancer risk

21 January 2018

1 reference

Cancer occurrence in Danish diabetic patients: duration and insulin effects

21 January 2018

1 reference

Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus

21 January 2018

1 reference

Selective versus total insulin resistance: a pathogenic paradox

21 January 2018

1 reference

The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance

21 January 2018

1 reference

Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver

21 January 2018

1 reference

Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation

21 January 2018

1 reference

Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis

21 January 2018

1 reference

Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression

21 January 2018

1 reference

Akt2 is required for hepatic lipid accumulation in models of insulin resistance.

21 January 2018

1 reference

Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

21 January 2018

1 reference

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

21 January 2018

1 reference

Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction

21 January 2018

1 reference

Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.

21 January 2018

1 reference

SREBPs suppress IRS-2-mediated insulin signalling in the liver

21 January 2018

1 reference

Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism

21 January 2018

1 reference

PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism

21 January 2018

1 reference

Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas

21 January 2018

1 reference

Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]

21 January 2018

1 reference

Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor

21 January 2018

1 reference

Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high

21 January 2018

1 reference

Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors

21 January 2018

1 reference

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

21 January 2018

1 reference

Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway.

21 January 2018

1 reference

Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

21 January 2018

1 reference

Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.

21 January 2018

1 reference

Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.

21 January 2018

1 reference

Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver

21 January 2018

1 reference

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

21 January 2018

1 reference

Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.

21 January 2018

1 reference

Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma

21 January 2018

1 reference

Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.

21 January 2018

1 reference

SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma

21 January 2018

1 reference

V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis

21 January 2018

1 reference

Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression

21 January 2018

1 reference

TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma

21 January 2018

1 reference

The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression

21 January 2018

1 reference

Insulin-like growth factor-I and the liver.

21 January 2018

1 reference

Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma

21 January 2018

1 reference

Leptin signaling in breast cancer: An overview

21 January 2018

1 reference

Insulin-dependent leptin expression in breast cancer cells.

21 January 2018

1 reference

Leptin in hepatocellular carcinoma

21 January 2018

1 reference

Obesity, adipokines and hepatocellular carcinoma

21 January 2018

1 reference

The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology

21 January 2018

1 reference

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.

21 January 2018

1 reference

Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.

21 January 2018

1 reference

Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells

21 January 2018

1 reference

Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis

21 January 2018

1 reference

Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia

21 January 2018

1 reference

The liver diseases of lipodystrophy: the long-term effect of leptin treatment

21 January 2018

1 reference

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

21 January 2018

1 reference

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis

21 January 2018

1 reference

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

Angiogenesis, adipokines and breast cancer

21 January 2018

1 reference

Cell and molecular mechanisms of insulin-induced angiogenesis

21 January 2018

1 reference

Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis

21 January 2018

1 reference

Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway

21 January 2018

1 reference

Insulin promotes sinusoidal endothelial cell proliferation mediated by upregulation of vascular endothelial growth factor in regenerating rat liver after partial hepatectomy

21 January 2018

1 reference

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

21 January 2018

1 reference

The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer

21 January 2018

1 reference

Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats

21 January 2018

1 reference

Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats

21 January 2018

1 reference

Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes

21 January 2018

1 reference

Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice

21 January 2018

1 reference

Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.

21 January 2018

1 reference

A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo

21 January 2018

1 reference

21 January 2018

1 reference

A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.

21 January 2018

1 reference

Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines

21 January 2018

1 reference

A tale of two receptors: insulin and insulin-like growth factor signaling in cancer

21 January 2018

1 reference

Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis

21 January 2018

1 reference